Vectus Biosystems Limited (ASX:VBS)
Australia · Delayed Price · Currency is AUD 0.1350
-0.0100 (-6.90%)
Sep 18, 2026, 3:38 PM AEST
Vectus Biosystems Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 0.72 | 0.25 | 0.81 | 2.95 | 1.28 |
Short-Term Investments | 2.8 | - | - | - | - |
Cash & Short-Term Investments | 3.52 | 0.25 | 0.81 | 2.95 | 1.28 |
Cash Growth | 1301.13% | -68.97% | -72.59% | 130.30% | -77.82% |
Other Receivables | 0.22 | 0.44 | 0.98 | 1.43 | 2.32 |
Receivables | 0.22 | 0.44 | 0.98 | 1.43 | 2.32 |
Inventory | - | 0 | 0 | 0 | 0 |
Prepaid Expenses | 0.06 | 0.09 | 0.06 | 0.07 | 0.13 |
Other Current Assets | - | 0.07 | - | - | - |
Total Current Assets | 3.8 | 0.85 | 1.84 | 4.46 | 3.73 |
Property, Plant & Equipment | 0.02 | 0 | 0.18 | 0.17 | 0.21 |
Total Assets | 3.82 | 0.85 | 2.03 | 4.63 | 3.94 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.6 | 0.43 | 0.19 | 0.22 | 0.12 |
Accrued Expenses | 0.35 | 0.3 | 0.29 | 0.54 | 1.3 |
Short-Term Debt | 0.04 | - | - | - | 0.44 |
Current Portion of Long-Term Debt | - | - | - | - | 5.45 |
Current Portion of Leases | 0.01 | - | 0.03 | 0.04 | 0.06 |
Other Current Liabilities | 0.01 | 0 | 0.03 | 0.03 | 0.03 |
Total Current Liabilities | 1 | 0.73 | 0.53 | 0.83 | 7.4 |
Long-Term Debt | 0.49 | 0.2 | - | - | - |
Long-Term Leases | 0.01 | - | - | 0.03 | 0.07 |
Pension & Post-Retirement Benefits | 0 | 0 | - | - | - |
Other Long-Term Liabilities | - | - | 0 | 0 | 0 |
Total Liabilities | 1.5 | 0.94 | 0.54 | 0.86 | 7.47 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 39.17 | 38.37 | 38.37 | 38.35 | 27.3 |
Retained Earnings | -37.77 | -39.33 | -37.73 | -35.39 | -32.18 |
Comprehensive Income & Other | 0.92 | 0.88 | 0.84 | 0.8 | 1.35 |
Shareholders' Equity | 2.32 | -0.08 | 1.49 | 3.77 | -3.53 |
Total Liabilities & Equity | 3.82 | 0.85 | 2.03 | 4.63 | 3.94 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.55 | 0.2 | 0.03 | 0.07 | 6.02 |
Net Cash (Debt) | 2.97 | 0.05 | 0.78 | 2.88 | -4.73 |
Net Cash Growth | 5724.90% | -93.46% | -72.92% | - | - |
Net Cash Per Share | 0.05 | 0.00 | 0.01 | 0.06 | -0.14 |
Filing Date Shares Outstanding | 61.69 | 53.28 | 53.21 | 53.19 | 37.03 |
Total Common Shares Outstanding | 61.69 | 53.28 | 53.21 | 53.19 | 36.26 |
Working Capital | 2.8 | 0.12 | 1.31 | 3.62 | -3.67 |
Book Value Per Share | 0.04 | -0.00 | 0.03 | 0.07 | -0.10 |
Tangible Book Value | 2.32 | -0.08 | 1.49 | 3.77 | -3.53 |
Tangible Book Value Per Share | 0.04 | -0.00 | 0.03 | 0.07 | -0.10 |
Machinery | 0.09 | 0.09 | 0.96 | 0.9 | 0.9 |